The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Seres Therapeutics Inc shares valued at $475 were sold by DesRosier Thomas on Nov 18 ’24. At $0.54 per share, DesRosier Thomas sold 878 shares. The insider’s holdings dropped to 135,192 shares worth approximately $0.11 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, von Moltke Lisa sold 977 shares, netting a total of over 528 in proceeds. Following the sale of shares at $0.54 each, the insider now holds 32,415 shares.
Before that, Shaff Eric D. had sold 2,505 shares from its account. In a trade valued at $1,355, the CEO and President traded Seres Therapeutics Inc shares for $0.54 each. Upon closing the transaction, the insider’s holdings decreased to 2,505 shares, worth approximately $0.14 million.
As published in a research note from JP Morgan on October 24, 2024, Seres Therapeutics Inc [MCRB] has been rated down from a Neutral to an Underweight. As of April 21, 2023, JP Morgan has initiated its “Neutral” rating for MCRB. Earlier on July 23, 2021, Goldman downgraded its rating. Their new recommendation was “a Sell” for MCRB stock which previously was a “a Neutral”.
Analyzing MCRB Stock Performance
During the last five days, there has been a drop of approximately -6.61%. Over the course of the year, Seres Therapeutics Inc shares have dropped approximately -41.50%. Shares of the company reached a 52-week high of $2.0500 on 01/09/24 and a 52-week low of $0.5400 on 04/19/24. A 50-day SMA is recorded $0.7936, while a 200-day SMA reached $0.8932. Nevertheless, trading volume fell to 1.9 million shares from 2.88 million shares the previous day.
Support And Resistance Levels for Seres Therapeutics Inc (MCRB)
According to the 24-hour chart, there is a support level at 0.7899, which, if violated, would cause prices to drop to 0.7607. In the upper region, resistance lies at 0.8583. The next price resistance is at 0.8975. RSI (Relative Strength Index) is 51.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0883, which suggests the price will decrease in the coming days. Percent R is at 40.69%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
